Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 20, 2024

SELL
$17.02 - $21.0 $1,565 - $1,932
-92 Reduced 0.44%
20,594 $375,000
Q1 2024

May 10, 2024

BUY
$20.45 - $26.49 $133,477 - $172,900
6,527 Added 46.1%
20,686 $447,000
Q4 2023

Feb 02, 2024

SELL
$19.02 - $30.13 $119,540 - $189,367
-6,285 Reduced 30.74%
14,159 $314,000
Q3 2023

Nov 14, 2023

SELL
$30.46 - $46.04 $731 - $1,104
-24 Reduced 0.12%
20,444 $622,000
Q2 2023

Aug 01, 2023

BUY
$31.57 - $37.73 $308,438 - $368,622
9,770 Added 91.33%
20,468 $764,000
Q1 2023

May 05, 2023

BUY
$29.72 - $41.45 $317,944 - $443,432
10,698 New
10,698 $341,000
Q2 2022

Jul 22, 2022

SELL
$20.97 - $37.47 $116,341 - $207,883
-5,548 Closed
0 $0
Q1 2022

Apr 22, 2022

SELL
$34.38 - $65.77 $21,453 - $41,040
-624 Reduced 10.11%
5,548 $205,000
Q4 2021

Feb 14, 2022

BUY
$63.78 - $97.86 $202,118 - $310,118
3,169 Added 105.53%
6,172 $435,000
Q3 2021

Nov 05, 2021

BUY
$45.58 - $88.24 $136,876 - $264,984
3,003 New
3,003 $226,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.